CARNISURE SYRUP
Out of Stock
Carnisure 500 mg Syrup 30 ml by Torrent Pharmaceuticals is a clinically formulated levocarnitine supplement designed to address a critical and often underdiagnosed condition in paediatric patients: carnitine deficiency. In children, primary carnitine deficiency is a metabolic disorder in which the body is unable to adequately transport long-chain fatty acids into the mitochondria for energy production, resulting in cellular energy failure that can manifest as muscle weakness, hypoglycaemia, cardiomyopathy, and developmental impairment. Secondary carnitine deficiencies arise in the context of chronic conditions such as end-stage renal disease requiring dialysis, certain metabolic disorders, and prolonged use of medications that deplete carnitine stores. Left unaddressed, these deficiencies compromise the energy supply to vital organs including the heart, skeletal muscle, and liver. Carnisure 500 mg Syrup targets this metabolic gap at its root by replenishing circulating and intracellular levocarnitine levels, thereby restoring fatty acid oxidation capacity and supporting overall cellular energy balance. Animeal is proud to offer this trusted prescription-grade nutritional supplement from one of India's foremost pharmaceutical manufacturers.
Ingredients:
L-Carnitine / Levocarnitine (500 mg per dose):
Levocarnitine is the biologically active stereoisomer of carnitine, a naturally occurring amino acid derivative biosynthesised in the liver and kidneys from the precursor amino acids lysine and methionine. At the cellular level, levocarnitine functions as an obligatory co-factor for the carnitine palmitoyl transferase (CPT) enzyme system located on the inner mitochondrial membrane. This transporter system is responsible for shuttling long-chain fatty acids (C12 to C18) across the otherwise impermeable inner mitochondrial membrane, where they undergo beta-oxidation to generate acetyl-CoA, the primary substrate for ATP synthesis via the Krebs cycle and oxidative phosphorylation. Without adequate levocarnitine, long-chain fatty acids accumulate in the cytoplasm, forming acylcarnitine esters that disrupt normal cellular metabolism, while mitochondrial energy production falls dramatically. In carnitine-deficient states, supplemental levocarnitine at 500 mg corrects this transport deficit, restores fatty acid flux into the mitochondrial matrix, normalises the intracellular acyl-CoA to free CoA ratio, and rescues energy production in carnitine-depleted tissues including cardiac muscle, skeletal muscle, and hepatocytes. Additionally, levocarnitine facilitates the elimination of accumulated organic acids and short-chain acylcarnitines in the urine, which is of particular relevance in patients with metabolic disorders and in those undergoing haemodialysis, in whom carnitine is rapidly lost through the dialysate membrane.
